Skip to main content

KURE · KraneShares MSCI All China Health Care Index ETF ETF

Krane Shares Trust

SEC fund profile
$18.90 -0.05% At close · Sep 4
Net assets $71,227,168
Holdings63
1 month
+1.94%
Year to date
+10.92%
52-week range
$14.38–$21.88
30-session avg volume
44,076

Market performance

Adjusted close · up to five years

Since Sep 2021

Fund profile

Structure
Open-end / ETF
SEC series
S000059796
Report date
Jun 30, 2026
Holdings coverage
Full reported portfolio

Portfolio concentration

Top 10 holdings54.14%

Calculated only when the SEC filing is stored with complete portfolio coverage.

Asset allocation

EC99.67%
STIV3.55%

Country allocation

HK52.67%
CN45.73%
US4.82%

Portfolio holdings

Latest linked SEC Form NPORT-P report.

Export CSV
HoldingValueWeight
BeOne Medicines AG$6,299,6328.84%
INNOVENT BIOLOGICS, INC.$6,267,8768.80%
WUXI BIOLOGICS (CAYMAN) INC.$5,350,2817.51%
WuXi AppTec Co., Ltd.$4,121,9635.79%
Jiangsu Hengrui Pharmaceuticals Co.,Ltd$3,269,0444.59%
Shenzhen Mindray Bio-Medical Electronics Co Ltd$3,044,6694.27%
Akeso Inc$2,649,7923.72%
CSPC PHARMACEUTICAL GROUP LIMITED$2,620,9673.68%
Invesco Government & Agency Portfolio$2,526,8043.55%
SINO BIOPHARMACEUTICAL LIMITED$2,411,2293.39%
WuXi AppTec Co., Ltd.$2,386,9013.35%
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED$2,032,0662.85%
3SBio Inc.$1,771,4792.49%
YUNNAN BAIYAO GROUP CO., LTD$1,641,5022.30%
Shanghai United Imaging Healthcare Co., Ltd.$1,618,1892.27%
Aier Eye Hospital Group Co., Ltd.$1,494,2512.10%
Sichuan Biokin Pharmaceutical Co Ltd$1,400,0641.97%
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd$1,318,2701.85%
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL CO., LTD.$1,235,3411.73%
SINOPHARM GROUP CO. LTD.$1,190,5041.67%
Sichuan Kelun Pharmaceutical Co., Ltd.$1,100,9811.55%
Haisco Pharmaceutical Group Co., Ltd.$1,086,7721.53%
HUADONG MEDICINE CO., LTD$969,1251.36%
WuXi XDC Cayman Inc$963,9221.35%
Shanghai Allist Pharmaceuticals Co Ltd$954,4221.34%
Legend Biotech Corp$909,3731.28%
RemeGen Co Ltd$896,4871.26%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.$882,2791.24%
Pharmaron Beijing Co., Ltd.$817,7581.15%
Shanghai Pharmaceuticals Holding Co., Ltd.$807,2341.13%
Genscript Biotech Corp$792,2471.11%
RemeGen Co Ltd$748,4911.05%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.$731,2601.03%
XtalPi Holdings Limited$709,1961.00%
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.$668,3600.94%
Shenzhen New Industries Biomedical Engineering Co Ltd$642,8700.90%
BEIJING TONG REN TANG CO., LTD$614,4850.86%
Shanghai RAAS Blood Products Co., Ltd.$560,1680.79%
Chongqing Zhifei Biological Products Co., Ltd.$543,2920.76%
CSPC Innovation Pharmaceutical Co Ltd$528,5420.74%
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD.$526,9520.74%
Imeik Technology Development Co Ltd$511,7930.72%
APT Medical Inc$497,4710.70%
Beijing Wantai Biological Pharmacy Enterprise Co Ltd$478,5390.67%
Hebei Changshan Biochemical Pharmaceutical Co Ltd$401,9490.56%
Hangzhou Tigermed Consulting Co., Ltd$324,2190.46%
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL CO., LTD.$54,7370.08%
Sichuan Kelun Pharmaceutical Co., Ltd.$48,8030.07%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.$45,0190.06%
Shanghai Pharmaceuticals Holding Co., Ltd.$25,4100.04%